Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses

The zoonotic Rift Valley fever virus (RVFV) can cause severe disease in humans and has pandemic potential, yet no approved vaccine or therapy exists. Here we describe a dual-mechanism human monoclonal antibody (mAb) combination against RVFV that is effective at minimal doses in a lethal mouse model...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Nathaniel S., Hulswit, Ruben J. G., Westover, Jonna L. B., Stass, Robert, Paesen, Guido C., Binshtein, Elad, Reidy, Joseph X., Engdahl, Taylor B., Handal, Laura S., Flores, Alejandra, Gowen, Brian B., Bowden, Thomas A., Crowe, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499838/
https://www.ncbi.nlm.nih.gov/pubmed/37704627
http://dx.doi.org/10.1038/s41467-023-41171-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499838/
https://www.ncbi.nlm.nih.gov/pubmed/37704627
http://dx.doi.org/10.1038/s41467-023-41171-3

Ejemplares similares